{"id":"https://openalex.org/W3136453073","doi":"https://doi.org/10.5958/0974-360x.2021.00220.1","title":"Formulation and evaluation of spherical crystal agglomerates of Lurasidone Hydrochloride","display_name":"Formulation and evaluation of spherical crystal agglomerates of Lurasidone Hydrochloride","publication_year":2021,"publication_date":"2021-01-01","ids":{"openalex":"https://openalex.org/W3136453073","doi":"https://doi.org/10.5958/0974-360x.2021.00220.1","mag":"3136453073"},"language":"en","primary_location":{"id":"doi:10.5958/0974-360x.2021.00220.1","doi":"https://doi.org/10.5958/0974-360x.2021.00220.1","is_oa":false,"landing_page_url":"https://doi.org/10.5958/0974-360x.2021.00220.1","pdf_url":null,"source":{"id":"https://openalex.org/S4210228335","display_name":"Research Journal of Pharmacy and Technology","issn_l":"0974-360X","issn":["0974-360X","0974-3618"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":["poland-20","russia-white-list-3"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"RESEARCH JOURNAL OF PHARMACY AND TECHNOLOGY","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5080923842","display_name":"Sanjesh Rathi","orcid":"https://orcid.org/0000-0002-5647-6097","observed_orcids":["https://orcid.org/0000-0002-5647-6097"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sanjeshkumar G. Rathi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052902687","display_name":"Sejal A. Zala","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sejal A. Zala","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004918669","display_name":"Maulikkumar D. Vaja","orcid":"https://orcid.org/0000-0001-7754-5023","observed_orcids":["https://orcid.org/0000-0001-7754-5023"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Maulikkumar D. Vaja","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5051144945","display_name":"Sohansinh S. Vaghela","orcid":"https://orcid.org/0000-0002-8519-577X","observed_orcids":["https://orcid.org/0000-0002-8519-577X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sohansinh S. Vaghela","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.507,"has_fulltext":false,"cited_by_count":5,"citation_normalized_percentile":{"value":0.51493443,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"14","issue":"3","first_page":"1238","last_page":"1246"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10256","display_name":"Drug Solubulity and Delivery Systems","score":0.9711999893188477,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10256","display_name":"Drug Solubulity and Delivery Systems","score":0.9711999893188477,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11881","display_name":"Crystallization and Solubility Studies","score":0.02759999968111515,"subfield":{"id":"https://openalex.org/subfields/2505","display_name":"Materials Chemistry"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10920","display_name":"Advanced Drug Delivery Systems","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/lurasidone-hydrochloride","display_name":"lurasidone hydrochloride","score":0.9990000128746033},{"id":"https://openalex.org/keywords/poorly-water-soluble-drugs","display_name":"poorly water-soluble drugs","score":0.8360000252723694},{"id":"https://openalex.org/keywords/water-solubility-enhancement","display_name":"aqueous solubility enhancement","score":0.902999997138977},{"id":"https://openalex.org/keywords/polyvinyl-alcohol","display_name":"polyvinyl alcohol","score":0.765999972820282},{"id":"https://openalex.org/keywords/polyethylene-glycol-4000","display_name":"polyethylene glycol 4000","score":0.9570000171661377},{"id":"https://openalex.org/keywords/saturation-solubility","display_name":"saturation solubility","score":0.7620000243186951},{"id":"https://openalex.org/keywords/dissolution-rate","display_name":"dissolution rate","score":0.5989999771118164},{"id":"https://openalex.org/keywords/tablet-formulation","display_name":"tablet formulation","score":0.6579999923706055},{"id":"https://openalex.org/keywords/direct-compression","display_name":"direct compression","score":0.5870000123977661},{"id":"https://openalex.org/keywords/factorial-design-optimization","display_name":"factorial design optimization","score":0.6449999809265137},{"id":"https://openalex.org/keywords/bcs-class-ii-drugs","display_name":"BCS class II drugs","score":0.7070000171661377}],"concepts":[{"id":"https://openalex.org/C2776701107","wikidata":"https://www.wikidata.org/wiki/Q416992","display_name":"Lurasidone","level":4,"score":0.8548316359519958},{"id":"https://openalex.org/C129955480","wikidata":"https://www.wikidata.org/wiki/Q1257738","display_name":"Agglomerate","level":2,"score":0.5924948453903198},{"id":"https://openalex.org/C33923547","wikidata":"https://www.wikidata.org/wiki/Q395","display_name":"Mathematics","level":0,"score":0.48222148418426514},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4442513585090637},{"id":"https://openalex.org/C2776460385","wikidata":"https://www.wikidata.org/wiki/Q420060","display_name":"Hydrochloride","level":2,"score":0.4129101634025574},{"id":"https://openalex.org/C28826006","wikidata":"https://www.wikidata.org/wiki/Q33521","display_name":"Applied mathematics","level":1,"score":0.34782782196998596},{"id":"https://openalex.org/C136229726","wikidata":"https://www.wikidata.org/wiki/Q327092","display_name":"Biomedical engineering","level":1,"score":0.3461196720600128},{"id":"https://openalex.org/C192562407","wikidata":"https://www.wikidata.org/wiki/Q228736","display_name":"Materials science","level":0,"score":0.3079981505870819},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.24282896518707275},{"id":"https://openalex.org/C159985019","wikidata":"https://www.wikidata.org/wiki/Q181790","display_name":"Composite material","level":1,"score":0.14150726795196533},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.09171068668365479},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.07758575677871704},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.0},{"id":"https://openalex.org/C2780494398","wikidata":"https://www.wikidata.org/wiki/Q208144","display_name":"Antipsychotic","level":3,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.5958/0974-360x.2021.00220.1","doi":"https://doi.org/10.5958/0974-360x.2021.00220.1","is_oa":false,"landing_page_url":"https://doi.org/10.5958/0974-360x.2021.00220.1","pdf_url":null,"source":{"id":"https://openalex.org/S4210228335","display_name":"Research Journal of Pharmacy and Technology","issn_l":"0974-360X","issn":["0974-360X","0974-3618"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":["poland-20","russia-white-list-3"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"RESEARCH JOURNAL OF PHARMACY AND TECHNOLOGY","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.6240000128746033}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2321842721","https://openalex.org/W2065617439","https://openalex.org/W7217023971","https://openalex.org/W4414888907","https://openalex.org/W4391858716","https://openalex.org/W2173845065","https://openalex.org/W3009561795","https://openalex.org/W4312193214","https://openalex.org/W1902392752","https://openalex.org/W2954390522"],"abstract_inverted_index":{"The":[0],"main":[1],"objective":[2],"of":[3,11,34,64,73,91,97,111,141,151,160,174],"the":[4,62],"study":[5,150],"was":[6,78,104,107,124,162,179,182],"to":[7],"improve":[8],"aqueous":[9],"solubility":[10,30,75,87,118,136,140,200],"poorly":[12],"water":[13],"soluble":[14],"drug.":[15,146],"Lurasidone":[16,35],"Hydrochloride":[17,36],"is":[18],"a":[19],"BCS":[20],"class":[21],"II":[22],"drug":[23,121],"and":[24,54,76,81,88,99,113,119,132,154,168,176],"has":[25],"low":[26],"solubility.":[27],"To":[28,94],"enhance":[29,116],"Spherical":[31,202],"Crystal":[32,203],"Agglomerates":[33,204],"were":[37,58,69],"formulated":[38],"using":[39,164],"solvent":[40,56],"exchange":[41],"method.":[42],"Different":[43],"process":[44],"parameter":[45],"like":[46],"good":[47],"solvent,":[48,50],"bad":[49,55],"agitation":[51],"time,":[52],"speed":[53],"volume":[57],"successfully":[59,126],"optimized":[60,95],"on":[61,71],"basis":[63],"various":[65,171],"evolution":[66],"parameters.":[67,172],"Polymers":[68],"screened":[70],"basic":[72],"saturation":[74,86,117],"it":[77,181],"found":[79,108,183],"PVA":[80,98,112],"PEG4000":[82],"mixture":[83],"giving":[84],"higher":[85],"better":[89],"morphology":[90],"spherical":[92],"crystal.":[93],"concentration":[96],"PEG":[100,114],"4000":[101,115],"factorial":[102],"design":[103],"adopted.":[105],"It":[106],"increase":[109,138],"amount":[110],"percentage":[120],"release.":[122],"Formulation":[123],"s":[125],"characterized":[127],"by":[128,170,201],"FTIR,":[129],"DSC,":[130],"XRD":[131],"particle":[133],"size.":[134],"Saturation":[135],"shows":[137],"in":[139,157,186,199],"formulation":[142,152,161],"as":[143],"compare":[144],"pure":[145],"In":[147],"vitro":[148],"dissolution":[149,187],"performed":[153],"observed":[155],"improvement":[156,185,198],"dissolution.":[158],"Tablet":[159],"prepared":[163,175],"direct":[165],"compression":[166],"method":[167],"evaluated":[169],"Dissolution":[173],"marketed":[177],"tablet":[178,190],"compared;":[180],"that":[184],"profile.":[188],"Prepared":[189],"showed":[191,197],"stability":[192],"after":[193],"one":[194],"month.":[195],"Results":[196],"approach.":[205]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2022,"cited_by_count":4}],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2021-03-29T00:00:00"}